DPIIT recognised startup Government of India
Startup India
Papyrus Diagnostics Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.27 Lakh
▲ 288% YoY
Net loss · FY 2025
₹2.26 Lakh
Net margin -52.8%
EBITDA · FY 2025
-₹1.87 Lakh
EBITDA margin -43.7%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹11,110
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Papyrus Diagnostics Private Limited
Data last updated:
Papyrus Diagnostics Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33119KA2021PTC149168.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹11,110. It is led by directors Bhushan Toley and Venkata Subramanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.27 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.26 Lakh (net margin -52.8%) and EBITDA of -₹1.87 Lakh (EBITDA margin -43.7%).
The company is associated with 1 brand: Papyrus DX.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website papyrusdx.com.
Company Details of Papyrus Diagnostics Private Limited
CIN U33119KA2021PTC149168
Registration Number 149168
Incorporation Date 07 July 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Papyrus Diagnostics
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo.235 Binnamangala 2nd Floor, 13th Cross Road 2nd Stage Indira Nagar, Bangalore, Karnataka, India – 560038
- IndustryHealthcare, Preventive Health Services
Comprehensive company report
Papyrus Diagnostics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Papyrus Diagnostics Private Limited
Papyrus Diagnostics operates one associated brand: Papyrus DX. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic devices for infectious diseases and antimicrobial resistance are developed. | papyrusdx.com |
Financials of Papyrus Diagnostics Private Limited FY 2025 filings available
Papyrus Diagnostics Private Limited reported revenue of ₹4.27 Lakh (up 288% YoY) for FY 2025.
Revenue · FY 2025
₹4.27 Lakh ▲ 288%
Net loss · FY 2025
₹2.26 Lakh margin -52.8%
EBITDA · FY 2025
-₹1.87 Lakh margin -43.7%
Compounded Annual Growth Rate (CAGR) of Papyrus Diagnostics Private Limited
Revenue CAGR growth
1 year
▲ 288%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 27%
Revenue rose 288% in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Papyrus Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.87 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.26 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Papyrus Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -43.7% | •••• | •••• | •••• |
| Net Profit Margin | -52.8% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Papyrus Diagnostics are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Papyrus Diagnostics Private Limited
Papyrus Diagnostics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhushan Toley | Director | 07 Jul 2021 | 5 Years 3 Months | Current |
| Venkata Subramanian | Director | 07 Jul 2021 | 5 Years 3 Months | Current |
Peer Comparison of Papyrus Diagnostics Private Limited
Papyrus Diagnostics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syn Corp Clincare Technologies Private Limited | ₹4.81 Lakh (FY 2024) | •••• | •••• | 3956.0% | •••• | Bengaluru, Karnataka, India |
| Assistaid Healthcare Private Limited | ₹4.72 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Kuantum Technologies Private Limited | ₹4.63 Lakh (FY 2016) | •••• | •••• | -99.0% | •••• | Mumbai, Maharashtra, India |
| Aureus Research Private Limited | ₹4.44 Lakh (FY 2024) | •••• | •••• | -79.0% | •••• | Sangli, Maharashtra, India |
| Celestis Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| Papyrus Diagnostics Private Limited this company | ₹4.27 Lakh (FY 2025) | •••• | •••• | 288.0% | •••• | Bangalore, Karnataka, India |
| Centella Scientific Private Limited | ₹4.06 Lakh (FY 2024) | •••• | •••• | 306.0% | •••• | Hyderabad, Telangana, India |
| Maha Ganapati Institute of Medical Science & Research | ₹3.91 Lakh (FY 2025) | •••• | •••• | -97.0% | •••• | West Bengal, India |
| Biomenovo Research Private Limited | ₹3.81 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Prothix Lifesciences Private Limited | ₹3.43 Lakh (FY 2025) | •••• | •••• | •••• | Raipur, Chhattisgarh, India | |
| Holborn Wells India Private Limited | ₹3.42 Lakh (FY 2023) | •••• | •••• | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Papyrus Diagnostics by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Papyrus Diagnostics Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Papyrus Diagnostics Private Limited
Papyrus Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Papyrus Diagnostics Private Limited
Papyrus Diagnostics Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Papyrus Diagnostics Private Limited
Papyrus Diagnostics Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Harinee Natarajan ceased to be Alternate Director on 10 Jul 2025.
AGM
Papyrus Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Harinee Natarajan ceased to be Alternate Director.
Filing
Papyrus Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Harinee Natarajan was appointed as Alternate Director.
Appointed
Bhushan Toley was appointed as Director.
Appointed
Venkata Subramanian was appointed as Director.
Incorporation
07 Jul 2021
Papyrus Diagnostics Private Limited was registered on 07 Jul 2021 with Roc Bangalore & aged 5 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Papyrus Diagnostics Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Papyrus Diagnostics Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Papyrus Diagnostics Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Papyrus Diagnostics Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Papyrus Diagnostics Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Papyrus Diagnostics Private Limited
Papyrus Diagnostics is an active private limited company based in Bangalore, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 July 2021 (5+ years old) and is registered under CIN U33119KA2021PTC149168.
Papyrus Diagnostics reported revenue of ₹4.27 Lakh for FY 2025 (up 288% YoY).
Papyrus Diagnostics has 2 current directors:
- Bhushan Toley - Director
- Venkata Subramanian - Director
Papyrus Diagnostics reported a net loss of ₹2.26 Lakh (net margin -52.8%) and EBITDA of -₹1.87 Lakh (EBITDA margin -43.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Papyrus Diagnostics is U33119KA2021PTC149168. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Papyrus Diagnostics was incorporated on 07 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Papyrus Diagnostics by revenue are Syn Corp Clincare Technologies Private Limited, Assistaid Healthcare Private Limited, Kuantum Technologies Private Limited, Aureus Research Private Limited, Celestis Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).
Harinee Natarajan ceased to be Alternate Director on 10 Jul 2025. Harinee Natarajan was appointed as Alternate Director on 17 Sep 2024. Bhushan Toley was appointed as Director on 07 Jul 2021. Papyrus Diagnostics has 4 board changes on record in total.
Yes, Papyrus Diagnostics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Papyrus Diagnostics can be reached through the website papyrusdx.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Papyrus Diagnostics is at No.235 Binnamangala 2nd Floor, 13th Cross Road 2nd Stage Indira Nagar, Bangalore, Karnataka, India – 560038.